While the CAI purports to isolate and shield CSP compounding operations, you can find a lot of elements which bear upon its successful operation which includes: Manufacturers planning to apply these approaches have to provide sturdy validation data to demonstrate their equivalence to pharmacopoeial procedures. As these new systems emerge,